Q&A with Ruiqi Jin: Understanding the Impact of Financial Toxicity on Cancer PatientsJanuary 29, 2024
Ruiqi Jin, a 2023 PhRMA Foundation predoctoral awardee, is studying how the financial burden associated with cancer affects patients and what could be changed to help.
During her clinical training to become a nurse, Ruiqi Jin cared for many cancer patients and heard their worries about the heavy financial burden they faced because of the disease.
Cancer patients often need expensive, long-term treatment, which can have adverse effects on their financial well-being. This “financial toxicity” often decreases cancer patients’ quality of life and overall health.
Now pursuing her PhD at Emory University, Jin is studying how financial toxicity changes over time and how it affects cancer patients. Specifically, she received a 2023 PhRMA Foundation Predoctoral Fellowship in Value Assessment-Health Outcomes Research for her work exploring financial toxicity for patients with chronic myeloid leukemia, a cancer of the bone marrow and blood, to identify factors that can be changed or improved to reduce financial toxicity.
Watch this video to learn about Jin and her research.